Chang-Youh Tsai Selected Research

Lipids

1/2018	Effects and mechanisms of caffeine to improve immunological and metabolic abnormalities in diet-induced obese rats.
1/2013	Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang-Youh Tsai Research Topics

Disease

18	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 08/2002
18	Rheumatoid Arthritis 01/2022 - 10/2004
16	Ankylosing Spondylitis 01/2021 - 10/2004
15	Inflammation (Inflammations) 03/2022 - 02/2007
10	Infections 03/2022 - 09/2006
7	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2010
7	Arthritis (Polyarthritis) 01/2019 - 04/2006
7	Lupus Nephritis 04/2018 - 09/2006
6	Neoplasms (Cancer) 03/2022 - 01/2012
4	Rheumatic Diseases (Rheumatism) 01/2022 - 02/2014
4	Fibrosis (Cirrhosis) 07/2020 - 01/2016
4	Uveitis 01/2019 - 04/2006
4	Psoriatic Arthritis 05/2018 - 04/2006
3	Hypersensitivity (Allergy) 01/2022 - 09/2015
3	Body Weight (Weight, Body) 12/2020 - 01/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2019 - 01/2016
3	Proteinuria 04/2019 - 06/2009
3	Chronic Renal Insufficiency 12/2018 - 01/2012
3	Necrosis 02/2018 - 02/2010
2	Immunoglobulin G4-Related Disease 01/2022 - 07/2020
2	Eosinophilia 01/2022 - 07/2018
2	Hepatitis B 11/2021 - 08/2021
2	Osteoporosis 01/2021 - 11/2008
2	Hepatitis 01/2020 - 08/2006
2	Bacteremia 02/2019 - 09/2012
2	Gangrene 01/2019 - 08/2006
2	Cough 12/2017 - 11/2016
2	Nephritis 01/2017 - 09/2012
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2016 - 03/2005
2	Leukemia 01/2014 - 07/2007
2	Cachexia 01/2013 - 01/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2012 - 05/2008
1	Death (Near-Death Experience) 05/2022
1	COVID-19 03/2022
1	Vasculitis (Vasculitides) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Liver Failure 08/2021
1	Sarcopenia 01/2021
1	Dysbiosis 01/2021
1	Phlebitis 07/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2020
1	Systemic Scleroderma (Systemic Sclerosis) 04/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2020
1	Hemolytic Anemia 01/2020

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 04/2020 - 02/2007
7	Etanercept (Enbrel)FDA Link 12/2020 - 01/2009
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2012
6	Rituximab (Mabthera)FDA Link 11/2021 - 05/2012
6	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 10/2004
6	AutoantibodiesIBA 07/2020 - 05/2009
5	Immunoglobulin G (IgG)IBA 01/2022 - 08/2010
5	Antirheumatic Agents (DMARD)IBA 11/2021 - 11/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 02/2007
5	C-Reactive ProteinIBA 07/2012 - 04/2006
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2015
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2021 - 02/2012
4	Biological ProductsIBA 11/2021 - 02/2018
4	AntibodiesIBA 04/2019 - 08/2006
4	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2019 - 04/2006
4	anti-dsDNA autoantibodyIBA 01/2017 - 07/2008
4	HLA Antigens (Human Leukocyte Antigens)IBA 02/2010 - 04/2006
4	Antinuclear AntibodiesIBA 05/2009 - 08/2006
3	Abatacept (Orencia)FDA Link 11/2021 - 01/2020
3	Interleukin-23 (Interleukin 23)IBA 01/2021 - 07/2012
3	Untranslated RNA (Noncoding RNA)IBA 01/2021 - 10/2019
3	Methylprednisolone FDA LinkGeneric 02/2019 - 01/2009
3	Immunoglobulin A (IgA)IBA 01/2019 - 04/2006
3	SteroidsIBA 01/2019 - 01/2009
3	Thalidomide (Thalomid)FDA Link 12/2016 - 01/2009
2	Immunoglobulin E (IgE)IBA 01/2022 - 07/2020
2	AntigensIBA 10/2020 - 07/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 04/2019 - 04/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2018 - 01/2009
2	LipidsIBA 01/2018 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2017 - 07/2007
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2016 - 07/2015
2	HLA-B Antigens (HLA-B)IBA 09/2015 - 05/2008
2	Hormones (Hormone)IBA 02/2014 - 01/2013
2	Interleukin-2 (IL2)IBA 08/2010 - 09/2006
2	Messenger RNA (mRNA)IBA 04/2010 - 09/2009
2	LigandsIBA 04/2010 - 01/2010
1	dicarboxydine (DCD)IBA 05/2022
1	Antiviral Agents (Antivirals)IBA 03/2022
1	golimumab FDA Link 01/2022
1	Hepatitis B Core AntigensIBA 08/2021
1	ametantrone (HAQ)IBA 01/2021
1	AminopeptidasesIBA 01/2021
1	Heavy MetalsIBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2020
1	3-nitrotyrosineIBA 12/2020
1	Tumor Necrosis Factor InhibitorsIBA 12/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2020
1	MicroRNAs (MicroRNA)IBA 04/2020
1	CollagenIBA 04/2020
1	Propranolol (Inderal)FDA LinkGeneric 01/2020

Therapy/Procedure

13	Therapeutics 01/2021 - 06/2009
3	Aftercare (After-Treatment) 01/2022 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2012 - 07/2007